FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2008
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

WEST COAST ASSET MANAGEMENT INC

2. Date of Event Requiring Statement (MM/DD/YYYY)
2/15/2008 

3. Issuer Name and Ticker or Trading Symbol

ANGIOTECH PHARMACEUTICALS INC [ANPI]

(Last)        (First)        (Middle)

2151 ALESSANDRO DR, STE 100

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            ___ X ___ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

VENTURA, CA 93001       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Angiotech Pharmaceuticals, Inc.   10003225   I   See footnote   (1)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
( 1)  The Reporting Persons may be deemed to be indirect beneficial owners of the shares because WCAM has the power to vote the shares pursuant to investor advisor agreements with the record owners. 2457050 shares are held in trust accounts, 655125 shares are held in IRA accounts, 2586500 shares are held in Foundation accounts, 60600 shares are held in corporate accounts, 3611400 shares are held in high net worth individuals' accounts, 228150 shares are held in LLC accounts, 219900 shares are held in LP accounts, and 184500 shares are held in profit sharing accounts (managed by WCAM).

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
WEST COAST ASSET MANAGEMENT INC
2151 ALESSANDRO DR
STE 100
VENTURA, CA 93001
X

Orfalea Paul J
2151 ALESSANDRO DRIVE
SUITE 100
VENTURA, CA 93001
X

Helfert Lance W
2151 ALESSANDRO DRIVE
SUITE 100
VENTURA, CA 93001
X

Lowe R Atticus
2151 ALESSANDRO DRIVE
SUITE 100
VENTURA, CA 93001
X


Signatures
/s/ Linda Schuman as Attorney-In-Fact 3/3/2008
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jun 2024 bis Jul 2024 Click Here for more Angiotech Pharmaceuticals - Common Shares (MM) Charts.
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jul 2023 bis Jul 2024 Click Here for more Angiotech Pharmaceuticals - Common Shares (MM) Charts.